Deborah Crouch

Array ( [id] => 4022477 [patent_doc_number] => 05882877 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Adenoviral vectors for gene therapy containing deletions in the adenoviral genome' [patent_app_type] => 1 [patent_app_number] => 8/895194 [patent_app_country] => US [patent_app_date] => 1997-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 33 [patent_no_of_words] => 32114 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/882/05882877.pdf [firstpage_image] =>[orig_patent_app_number] => 895194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4247957 [patent_doc_number] => 06136792 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Prostate specific enhancer polynucleotides and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/891581 [patent_app_country] => US [patent_app_date] => 1997-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 12 [patent_no_of_words] => 13591 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136792.pdf [firstpage_image] =>[orig_patent_app_number] => 891581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4295573 [patent_doc_number] => 06235969 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Cloning pigs using donor nuclei from non-quiescent differentiated cells' [patent_app_type] => 1 [patent_app_number] => 8/888057 [patent_app_country] => US [patent_app_date] => 1997-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10454 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235969.pdf [firstpage_image] =>[orig_patent_app_number] => 888057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4067421 [patent_doc_number] => 05866759 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Transgenic mice expressing TSSV40 large T antigen' [patent_app_type] => 1 [patent_app_number] => 8/887095 [patent_app_country] => US [patent_app_date] => 1997-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18342 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866759.pdf [firstpage_image] =>[orig_patent_app_number] => 887095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407655 [patent_doc_number] => 06265218 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Plasmids without a selection marker gene' [patent_app_type] => 1 [patent_app_number] => 8/793618 [patent_app_country] => US [patent_app_date] => 1997-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7100 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265218.pdf [firstpage_image] =>[orig_patent_app_number] => 793618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636202 [patent_doc_number] => 06380458 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Cell-lineage specific expression in transgenic zebrafish' [patent_app_type] => B1 [patent_app_number] => 08/871755 [patent_app_country] => US [patent_app_date] => 1997-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 15232 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380458.pdf [firstpage_image] =>[orig_patent_app_number] => 08871755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4292218 [patent_doc_number] => 06211428 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Transgenic mouse expressing a familial form of human amyloid precursor protein' [patent_app_type] => 1 [patent_app_number] => 8/793558 [patent_app_country] => US [patent_app_date] => 1997-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6893 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/211/06211428.pdf [firstpage_image] =>[orig_patent_app_number] => 793558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4002136 [patent_doc_number] => 06004803 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Genes encoding HSV1-TK containing a deletion of 5\' cryptic promoter sites, vectors and cell lines' [patent_app_type] => 1 [patent_app_number] => 8/793518 [patent_app_country] => US [patent_app_date] => 1997-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6317 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004803.pdf [firstpage_image] =>[orig_patent_app_number] => 793518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4418375 [patent_doc_number] => 06194389 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Particle-mediated bombardment of DNA sequences into tissue to induce an immune response' [patent_app_type] => 1 [patent_app_number] => 8/840224 [patent_app_country] => US [patent_app_date] => 1997-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6199 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 288 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194389.pdf [firstpage_image] =>[orig_patent_app_number] => 840224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4124013 [patent_doc_number] => 06127170 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Multifunctional complexes for gene transfer into cells comprising a nucleic acid bound to a polyamine and having a endosome disruption agent' [patent_app_type] => 1 [patent_app_number] => 8/809397 [patent_app_country] => US [patent_app_date] => 1997-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34803 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 915 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127170.pdf [firstpage_image] =>[orig_patent_app_number] => 809397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640203 [patent_doc_number] => 06395712 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy' [patent_app_type] => B1 [patent_app_number] => 08/809021 [patent_app_country] => US [patent_app_date] => 1997-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 84 [patent_no_of_words] => 46613 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395712.pdf [firstpage_image] =>[orig_patent_app_number] => 08809021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407874 [patent_doc_number] => 06228646 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Helper-free, totally defective adenovirus for gene therapy' [patent_app_type] => 1 [patent_app_number] => 8/812618 [patent_app_country] => US [patent_app_date] => 1997-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 20 [patent_no_of_words] => 16203 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228646.pdf [firstpage_image] =>[orig_patent_app_number] => 812618 [rel_patent_id] =>[rel_patent_doc_number] =>)